# Virelion Biotech

> **Engineering the Heart.**

Virelion Biotech is an early-stage biotechnology venture building computational and experimental infrastructure for **cardiac regeneration, cardiac phenotyping, translational research, and biological decision support**.

Our public work is centered on a modular research stack: organize cardiac evidence, design better experiments, measure electrical/mechanical/imaging phenotypes, model biological state, evaluate algorithms rigorously, and connect the pieces through reproducible infrastructure.

The long-term objective is translational: use better measurement, better computation, and better experimental design to accelerate the development of technologies that restore cardiac function.

**Founded:** 2024  
**Founder:** Syed Umer Hannan  
**Website:** https://virelionbiotech.netlify.app/  
**GitHub:** https://github.com/Virelion-Biotech  
**Contact:** [virelion85@gmail.com](mailto:virelion85@gmail.com)

---

## What Virelion is building

Virelion's current public technology is organized as a connected cardiac research stack rather than a collection of unrelated applications.

```text
                    CARDIAC RESEARCH
                           │
        ┌──────────────────┼──────────────────┐
        │                  │                  │
     EVIDENCE          EXPERIMENT          MEASUREMENT
        │              DESIGN / SIM             │
        │                  │                  │
  CardiAtlas      CardiStudio · CardiSim   ElectroTrace
        │                                      MyoTrace
        │                                      OptiCell
        └──────────────────┬───────────────────┘
                           │
                  BIOLOGICAL STATE
                           │
                    CardiLearn
                           │
             ┌─────────────┴─────────────┐
             │                           │
        EVALUATION                  REPRODUCIBILITY
             │                           │
 CardiBench · CardiEval             CardiTrace
 CardioScore · CardiVex             CardiBridge
 DCCP · CardiAgent
             │                           │
             └─────────────┬─────────────┘
                           │
                       HEARTTWIN
                  orchestration layer
```

The stack is designed so that individual repositories can be used independently while sharing explicit data, evaluation, provenance, and interoperability contracts.

---

## Public technology portfolio

### Evidence and data foundation

**[CardiAtlas](https://github.com/Virelion-Biotech/Virelion-CardiAtlas)** — structured cardiac biomedical metadata, evidence, phenotypes, datasets, samples, claims, provenance, and PubMed/GEO retrieval. It emphasizes controlled terminology, identifier normalization, contradiction-aware claims, and deterministic release artifacts.

**[CardiBench](https://github.com/Virelion-Biotech/Virelion-CardiBench)** — benchmark registry and dataset-management layer for cardiac machine-learning evaluation. It defines biological grouping rules, split policies, leakage checks, benchmark manifests, and reproducible benchmark artifacts.

### Experimental design and simulation

**[CardiStudio](https://github.com/Virelion-Biotech/Virelion-CardiStudio)** — experimental-design and study-planning toolkit covering factorial designs, replicates, blocking, randomization, synthetic populations, longitudinal trajectories, biological constraints, and approximate power planning.

**[CardiSim](https://github.com/Virelion-Biotech/Virelion-CardiSim)** — seeded simulator for synthetic cardiac-cell and cardiac-phenotype trajectories under controlled perturbations, intended for hypothesis generation, benchmark construction, software testing, and model evaluation. Its state variables are abstractions rather than direct biological measurements.

### Cardiac measurement and phenotyping

**[ElectroTrace](https://github.com/Virelion-Biotech/Virelion-ElectroTrace)** — ECG/electrophysiology signal toolkit for import, annotation, R-peak detection, beat segmentation, phenotype extraction, statistics, and leakage-aware evaluation. It supports CSV, EDF/EDF+, and WFDB ZIP workflows and includes held-out MIT-BIH and external INCART validation work.

**[MyoTrace](https://github.com/Virelion-Biotech/Virelion-MyoTrace)** — video/TIFF analysis toolkit for cardiac-cell and tissue motion, beat timing, contraction/relaxation features, signal quality, repeatability, and optional multimodal feature fusion. Force interpretation requires instrument-specific calibration.

**[OptiCell](https://github.com/Virelion-Biotech/Virelion-OptiCell)** — microscopy QC, segmentation, tracking, phenotyping, and experiment-level quantitative analysis. The project explicitly prioritizes measured benchmarks and reproducible QC rather than fabricated performance claims.

### Molecular and biological-state modeling

**[CardiLearn](https://github.com/Virelion-Biotech/Virelion-CardiLearn)** — research codebase for cardiac transcriptomic representation learning and downstream prediction, including learned molecular programs, latent representations, biological-state prediction, interpretability, perturbation prediction, and leakage-aware biological splitting.

The larger CardiLearn architecture remains a **research target**, not a validated cardiac foundation model.

### Evaluation, safety, and challenge infrastructure

**[CardioScore](https://github.com/Virelion-Biotech/Virelion-CardioScore)** — configurable research framework for human iPSC-cardiomyocyte MEA data, combining electrophysiology endpoints, uncertainty analysis, dose-response diagnostics, and transparent risk scoring. It is research software and is **not a validated regulatory assay**.

**[CardiEval](https://github.com/Virelion-Biotech/Virelion-CardiEval)** — independent evaluator for submitted cardiac-model predictions against versioned benchmark packages, with classification/regression/ranking metrics, confidence intervals, paired comparisons, subgroup analysis, and reproducible evaluation artifacts.

**[CardiVex](https://github.com/Virelion-Biotech/Virelion-CardiVex)** — evaluation framework for cardiac challenge scenarios, including detection, characterization, novelty/OOD behavior, recovery, uncertainty, calibration, and longitudinal benchmarks.

**[DCCP](https://github.com/Virelion-Biotech/Virelion-DCCP)** — defensive computational challenge platform for testing cardiac models against controlled phenotypic challenge scenarios, OOD cases, and recovery behavior without recreating underlying biological threats.

**[CardiAgent](https://github.com/Virelion-Biotech/Virelion-CardiAgent)** — reproducible generation of phenotype-level cardiac challenge cases, including heterogeneous, temporal, noisy, partial-observation, and adaptive challenge populations.

**[Biosafety Assessment](https://github.com/Virelion-Biotech/Virelion-Biosafety-Assessment)** — rule-based planning aid for cardiac stem-cell and gene-therapy workflows, covering containment suggestions and related engineering-control, waste, training, and documentation considerations. It is **not a substitute for institutional biosafety review or IBC/Biosafety Officer approval**.

### Reproducibility and interoperability

**[CardiTrace](https://github.com/Virelion-Biotech/Virelion-CardiTrace)** — provenance and reproducibility layer for computational runs, artifacts, lineage, execution fingerprints, integrity metadata, trace bundles, and replay comparison.

**[CardiBridge](https://github.com/Virelion-Biotech/Virelion-CardiBridge)** — typed interoperability layer defining versioned message contracts, schema compatibility, routing, idempotency, persistence boundaries, authorization/signing primitives, and conformance testing.

### Orchestration

**[HeartTwin](https://github.com/Virelion-Biotech/Virelion-HeartTwin)** — orchestration and integration layer for the Virelion cardiac research stack. HeartTwin provides service discovery, typed cardiac-state contracts, adapters, a unified Python/CLI interface, health checks, and workflow composition.

HeartTwin is the intended integration surface for the stack, but **service registration is not the same as a completed native integration**. The repository currently documents several services as registered while native adapters are still being developed.

### Research intelligence

**[Cardiac Regenerative Lab Autocrawler](https://github.com/Virelion-Biotech/Cardiac-Regenerative-Lab-Autocrawler)** — multi-source research-intelligence pipeline covering cardiac regeneration, engineered heart tissue, direct reprogramming, stem-cell therapy, and biological pacing. It combines publications, grants, clinical trials, patents, institutional web sources, structured extraction, entity resolution, activity scoring, annual diffing, funding analysis, and trial-landscape reporting.

### Experimental / educational work

**[CARDIAC//BREACH](https://github.com/Virelion-Biotech/CARDIAC-BREACH)** — browser-based medical strategy game built around a fictional synthetic cardiac-tissue model. It is an educational/entertainment project rather than a biological intervention platform.

---

## How the stack fits together

Virelion's development philosophy is increasingly **measurement-first and evaluation-first**:

**1. Define the biological question.**  
Start from the phenotype or translational problem rather than from a preferred algorithm.

**2. Build the study correctly.**  
Use explicit experimental factors, biological replicates, blocking, randomization, constraints, and power planning where appropriate.

**3. Capture the phenotype.**  
Electrical, mechanical, imaging, and molecular measurements should be represented with explicit metadata and provenance.

**4. Represent biological state.**  
Translate measurements into structured cardiac-state representations suitable for downstream modeling.

**5. Evaluate under realistic splits.**  
Use benchmark manifests, biological grouping, leakage checks, held-out studies, subgroup analysis, uncertainty, and reproducible evaluation artifacts.

**6. Preserve the evidence trail.**  
Record inputs, transformations, outputs, lineage, hashes, versions, and execution context.

**7. Orchestrate only where contracts are clear.**  
HeartTwin and CardiBridge provide the integration layer; specialist repositories retain their own domain logic.

---

## Scientific philosophy

### Evidence before inference

The software stack is designed to distinguish **observed, inferred, and simulated** information. Missing measurements should remain missing rather than being silently interpreted as negative findings.

### Biological units matter

Cells, wells, recordings, samples, donors, animals, and studies are not interchangeable statistical units. The benchmark and evaluation tooling is designed to make biological grouping and leakage visible.

### Reproducibility is part of the science

Virelion treats provenance, deterministic manifests, hashes, trace records, and explicit versioning as part of the research workflow rather than as an afterthought.

### Validation is layered

Software tests, benchmark integrity, external dataset performance, biological validation, and clinical validation are different claims. Passing one layer does not establish the next.

---

## Current development status

Virelion is currently an **early-stage research and biotechnology venture**.

The public GitHub organization is primarily a record of active computational research infrastructure and prototypes. Some repositories are mature software tools with validation artifacts; others are research architectures, integration components, or experimental projects.

The current public stack should therefore **not** be interpreted as a collection of clinically validated products. In particular:

- Virelion does not currently claim regulatory approval for its public software.
- CardioScore is not a validated regulatory assay.
- CardiLearn is not a validated cardiac foundation model.
- CardiSim is not a validated physiological model or digital twin.
- HeartTwin is an integration/orchestration system, not by itself a clinically validated digital twin.
- Synthetic challenge and simulation outputs are computational representations, not empirical patient or animal measurements.
- Biosafety Assessment is a planning aid, not institutional biosafety approval.

Therapeutic and biological discovery programs may use this infrastructure, but repository functionality should not be read as evidence of clinical efficacy, safety, or regulatory acceptance.

---

## Open-source strategy

Virelion uses open-source software to expose research infrastructure, evaluation methods, interoperability contracts, and reproducibility practices while allowing higher-level biological development to evolve independently.

Most of the current Virelion research repositories use **AGPL-3.0-or-later**; individual repositories may use different licenses where appropriate. Check each repository's `LICENSE` for the authoritative terms.

The GitHub organization is the most reliable source for current implementation details, validation artifacts, and project-level status.

---

## Research intelligence and collaboration

Virelion is particularly interested in collaborations spanning:

- Cardiac regenerative medicine
- Cardiomyocyte maturation and engineering
- Cardiac electrophysiology and phenotyping
- Tissue engineering and electromechanical integration
- Computational biology and machine learning
- Experimental design and biostatistics
- Translational and regulatory science
- Reproducible scientific software

For scientific or partnership inquiries, include your background, organization, relevant technical or biological area, and the type of collaboration you are proposing.

---

## Contact

**Email:** [virelion85@gmail.com](mailto:virelion85@gmail.com)  
**Website:** https://virelionbiotech.netlify.app/  
**GitHub:** https://github.com/Virelion-Biotech

---

*Last reviewed against the public Virelion-Biotech repository portfolio: September 2026.*
